EyePoint EYPT Insider Ownership

Updated Oct 5, 2026

Over the past year, EYPT insiders bought $71,982 of stock (12.1K shares) and sold $2.04 million (127.45K shares) on the open market.

• Behind EyePoint's open-market trades in the past 12 months were 2 insiders buying and 3 insiders selling.
• Among EYPT insiders, Karen L. Zaderej (Director) bought the most stock on the open market in the past 12 months: $52,258 (10.6K shares), most recently on August 18, 2026.
• On the selling side, Ramiro Ribeiro (Chief Medical Officer) was the top open-market seller of EyePoint over the past 12 months, with $948,771 sold (57.45K shares) and the latest sale on June 30, 2026.
• Apart from open-market trades, EYPT insiders acquired 319.15K shares through option exercises and conversions, gave up 81.28K shares to cover taxes or exercise prices and gave away 74.95K shares as gifts in the past 12 months.
• Per Business Quant data, EyePoint insiders hold 9.09Mn shares in total based on their latest Form 4 filings, or 10.50% of the 86.54Mn shares outstanding; that total is up 0.20% from 9.07Mn shares at the end of Q2 2026 and down 2.00% from 9.27Mn shares at the end of Q3 2025.
• By type of ownership, EYPT insiders hold 4.73% of their shares directly (430.07K shares) and 95.27% indirectly (8.66Mn shares).
• Per Business Quant, 8 insiders of EYPT hold shares, counting officers, directors and 10% owners who have filed a Form 4 in the past two years.
• EyePoint's three largest insider shareholders, based on their latest Form 4 filings, are Cormorant Asset Management, LP (8.27Mn shares), Nancy Lurker (Director, 421.24K shares) and Jay S. Duker (President and CEO, 187.03K shares).
• Cormorant Asset Management, LP holds 90.93% of the combined insider position in EyePoint.
• In the past year, 12 insiders of EyePoint submitted 31 Form 4 filings reporting trades, awards or other transactions.
• The insider holdings and trades above for EyePoint reflect Form 4 filings through August 24, 2026.